Expanded Access of Onvansertib With FOLFIRI and Bevacizumab for the Second-Line Treatment of Participants With KRAS-Mutated Metastatic Colorectal Cancer

Name: Expanded Access of Onvansertib With FOLFIRI and Bevacizumab for the Second-Line Treatment of Participants With KRAS-Mutated Metastatic Colorectal Cancer
Creator: 暂无描述
License: 暂无描述

NIAID Data Ecosystem2026-03-06 收录

下载链接：

https://www.omicsdi.org/dataset/ecrin-mdr-crc/2343718

下载链接

链接失效反馈

官方服务：

资源简介：

This is an expanded access program for eligible participants designed to provide access to onvansertib in combination with FOLFIRI and bevacizumab.

创建时间：

1900-01-01